Paclitaxel|[ndash]|ifosfamide|[ndash]|carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

C Kosmas; G Vorgias; G Tsakonas; P Politis; T Daladimos; E Panagiotidi; T Papachrysanthou; D Moschovis; N Kalinoglou; N Tsavaris; A Karabelis; N Mylonakis

首页> 外文期刊>British Journal of Cancer >Paclitaxel|[ndash]|ifosfamide|[ndash]|carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

【24h】

Paclitaxel|[ndash]|ifosfamide|[ndash]|carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

机译：紫杉醇| [ndash] |异环磷酰胺| [ndash] |卡铂联合化疗方案治疗晚期子宫和附件恶性穆勒混合性肿瘤

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:Malignant mixed Mullerian tumours (MMMTs) of the uterus and adnexa represent aggressive gynaecologic malignancies with a high rate of loco-regional and distant failure. For that reason, we evaluated the paclitaxel–ifosfamide–carboplatin (TICb) combination in patients with advanced MMMTs.

机译：背景：子宫和附件的恶性混合穆勒氏肿瘤（MMMT）代表侵袭性妇科恶性肿瘤，局部和远处失败率很高。因此，我们评估了晚期MMMT患者的紫杉醇－异环磷酰胺－卡铂（TICb）组合。

著录项

来源
《British Journal of Cancer》 |2011年第7期|共6页
作者
C Kosmas; G Vorgias; G Tsakonas; P Politis; T Daladimos; E Panagiotidi; T Papachrysanthou; D Moschovis; N Kalinoglou; N Tsavaris; A Karabelis; N Mylonakis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Paclitaxel|[ndash]|ifosfamide|[ndash]|carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours [J] . C Kosmas, G Vorgias, G Tsakonas, British Journal of Cancer . 2011,第7期

机译：紫杉醇| [ndash] |异环磷酰胺| [ndash] |卡铂联合化疗方案治疗晚期子宫和附件恶性穆勒混合性肿瘤
2. Phase I|[sol]|II study of DHA|[ndash]|paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours [J] . M Harries, A ODonnell, M Scurr, British Journal of Cancer . 2004,第9期

机译：DHA | n-紫杉醇联合卡铂治疗晚期恶性实体瘤的I期| [sol] | II期研究
3. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. [J] . Hoskins PJ, Le N, Ellard S, Gynecologic Oncology: An International Journal . 2008,第1期

机译：卡铂加紫杉醇用于晚期或复发性子宫恶性混合苗勒氏瘤。不列颠哥伦比亚省癌症局的经验。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Paclitaxel–ifosfamide–carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours [O] . C Kosmas, G Vorgias, G Tsakonas, 2011

机译：紫杉醇-异环磷酰胺-卡铂联合化疗方案治疗晚期子宫和附件恶性混合性穆勒氏肿瘤
6. 320P Adjuvant chemotherapy comprising a paclitaxel and carboplatin regimen or paclitaxel and ifosfamide regimen for uterine carcinosarcoma, a single institutional retrospective study [O] . Y. Ohtake, T. Nishikawa, H. Yoshida, 2016

机译：320p辅助化疗，包括紫杉醇和卡铂治疗方案或紫杉醇和紫花苜蓿，用于子宫癌肉瘤，单一制度回顾性研究

Paclitaxel|[ndash]|ifosfamide|[ndash]|carboplatin combination chemotherapy regimen in advanced uterine and adnexal malignant mixed Mullerian tumours

摘要

著录项

相似文献

相关主题

期刊订阅